BN
Bhavna Nikhil Ashra
About Bhavna Nikhil Ashra
Data last updated:
Bhavna Nikhil Ashra has 13 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Disha Apis Private Limited and Ashtel Pharmed Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Disha Apis Private Limited at ₹5.91 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Apr 2013 | 2013 | ₹5.91 Cr (FY 2024) | Active | |
| Designated Partner | 28 Dec 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavna Nikhil Ashra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavna Nikhil Ashra
Bhavna Nikhil Ashra has 13 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Disha Apis Private Limited and Ashtel Pharmed Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Disha Apis Private Limited at ₹5.91 Cr (FY 2024).
Bhavna Nikhil Ashra is associated with 2 companies as Director and Designated Partner, including Disha Apis Private Limited (₹5.91 Cr), Ashtel Pharmed Llp.
Bhavna Nikhil Ashra has expertise in General Business.
Bhavna Nikhil Ashra has 13 years in corporate governance.
By reported revenue, the largest current company of Bhavna Nikhil Ashra is Disha Apis Private Limited, with revenue of ₹5.91 Cr (FY 2024).
Bhavna Nikhil Ashra currently holds positions at 2 companies: Disha Apis Private Limited (₹5.91 Cr), Ashtel Pharmed Llp.